Incb001158 drug page Clinical trials

Trials with Incb001158

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

3Trials
0Recruiting
6Countries
414Planned patients

Showing 1–3 of 3

A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors
Finished Phase 1 5 patients NCT03361228

The purpose of this study is to assess the safety and antitumor activity of INCB001158 plus epacadostat, with or without pembrolizumab, in participants with advanced or metastatic solid tumors.

United States Mar 2018 – Mar 2019 Interventional
Combined with: EpacadostatPembrolizumab
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Finished Phase 1 149 patients NCT03314935

The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in combination with chemotherapy in participants with advanced/metastatic solid tumors.

United States, Belgium, United Kingdom Nov 2017 – Nov 2022 Interventional
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Finished Phase 1 260 patients NCT02903914

This study is an open-label Phase 1/Phase 2 evaluation of INCB001158 as a single agent and in combination with immune checkpoint therapy in patients with advanced/metastatic solid tumors.

United States, Italy, Netherlands, Spain Sept 2016 – Aug 2022 Interventional
Combined with: Pembrolizumab